Therapix Biosciences

Termination of coverage 12 February 2020 Termination

Edison Investment Research is terminating coverage on Therapix Biosciences. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.


Share this with friends and colleagues